Clinical trials
Radiation clinical trials
Below are recruiting radiation clinical trials, each written for real people, not researchers. We’re tracking 1,030 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03480971RecruitingPhase 2
Tempol to reduce mouth and other side effects from radiation and cisplatin
This Phase 2 trial tests tempol to lessen harmful side effects caused by head-and-neck radiation and the chemotherapy drug cisplatin. If you qualify, you may receive tempol during treatment to help protect normal tissues and reduce toxicity.
La Jolla, CaliforniaAges 18 years+ - NCT07622667Recruiting
Gene Study of Cancer Tissue to Predict Treatment Outcomes
This study analyzes genetic information from cancer tumor samples to understand how genes affect treatment response and survival. By looking at leftover tissue or blood samples, researchers hope to better predict which treatments might work best for individual patients.
Guangzhou, GuangdongAges 18 years+ - NCT07627334Recruiting
Personalized drug testing for newly diagnosed brain tumors
This trial tests whether customized drug screening on your tumor cells can help doctors choose the best treatment for you. Your tumor cells will be grown in the lab and tested against different drugs to find what works best, combined with short-course radiation therapy.
Vienna, State of ViennaAges Any age - NCT05224297Recruiting
Help us improve radiation care by sharing your experiences
This study collects patient-reported experiences and side effects from people getting external beam radiation (radiation treatment from outside the body). Your answers can help doctors improve how radiation care is delivered and supported.
Vienna, State of ViennaAges 18–100 - NCT06033183Recruiting
Study of radiation sensitivity in children with cancer
This study looks at how children's bodies respond to radiation therapy for certain cancers. By analyzing blood samples, researchers hope to learn why some children experience more side effects, which could help personalize future treatments.
CaenAges 3–18 - NCT06702826RecruitingPhase 2
Cadonilimab plus radiation for lung cancer brain mets
This trial tests a combination of a targeted immunotherapy drug (cadonilimab) with a precise type of radiation to treat brain tumors that have grown after initial lung cancer treatment. The goal is to see if this approach can safely shrink brain metastases and improve outcomes.
Changsha, HunanAges 18–75 - NCT06704555RecruitingPhase 2
Radiation plus drug combo for untreated bulky follicular lymphoma
This trial tests a combination of radiation, an immunotherapy drug (tislelizumab), and chemotherapy (RCHOP) for people with previously untreated bulky follicular lymphoma. It aims to see if giving radiation first followed by the drug combo can improve outcomes for larger tumors.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT07617688RecruitingEarly Phase 1
PET imaging tracer safety study in healthy volunteers
This early-stage study tests a new PET imaging agent (a radioactive tracer used in medical imaging) to understand how it moves through the body and the radiation dose it delivers. Researchers need healthy volunteers to help establish whether this imaging tool is safe for future patient use.
New Haven, ConnecticutAges 18–60 - NCT06705127RecruitingPhase 2
Radiation, chemo, and immunotherapy for HR+ breast cancer
This trial tests if giving radiation first, then chemo with an immunotherapy drug called Toripalimab, can help treat a certain type of breast cancer that has not spread to other organs. It is for people with hormone receptor positive, HER2 negative breast cancer that is growing fast.
Hangzhou, ZhejiangAges 18–75 - NCT07604116RecruitingPhase 1
Testing a new imaging agent for Parkinson's and related conditions
This study tests an investigational imaging agent called SST001, which may help doctors see a protein linked to Parkinson's disease (PD) and multiple system atrophy (MSA) in the body. It will be given to healthy volunteers and patients with PD or MSA to check safety, how it spreads, and how the body handles it.
Wuxi, JiangsuAges 18 years+ - NCT07607119Recruiting
PULSAR radiation plus immunotherapy for advanced gastric cancer
This trial tests combining PULSAR (a type of radiation therapy) with immunotherapy drugs to treat gastric (stomach) cancer that cannot be surgically removed. You must have already completed at least 3 months of chemotherapy with immunotherapy and shown no cancer growth to qualify.
Seoul, Select Province/StateAges 19 years+ - NCT02573636Recruiting
Testing genes in prostate cancer after radiation relapse
This study looks at specific gene changes (TMPRSS2-ERG fusion and PTEN deletion) in people whose prostate cancer returned after radiation. It aims to understand who may have a higher risk of relapse and help predict outcomes after salvage or radical radiation.
Chicoutimi, QuebecAges 18 years+ - NCT07600957Recruiting
Polarized Light Therapy to Ease Radiation Skin Damage
This trial tests whether a special type of light therapy can reduce skin damage and irritation that happens during radiation treatment for breast cancer. If it works, it could help patients feel more comfortable during and after their radiation therapy.
Banī SuwayfAges 35–55 - NCT07603375RecruitingPhase 2
Chemotherapy and radiation for esophageal adenocarcinoma
This trial tests a combination of chemotherapy drugs given together with radiation therapy, followed by additional chemotherapy, for newly diagnosed adenocarcinoma (a type of cancer) in the esophagus or where the esophagus meets the stomach. The goal is to shrink the tumor and improve survival.
Durham, North CarolinaAges 18 years+ - NCT07594132Recruiting
New fluoroscopy imaging system during endoscopy procedures
This trial compares a newer imaging system with a standard imaging system used during endoscopy procedures (a camera test of your digestive tract or other internal areas). The study aims to see if the newer system provides better images or reduces radiation exposure.
Orlando, FloridaAges 18 years+ - NCT07594431RecruitingPhase 2
New radiation therapy for cancer that has spread to the body
This study tests a newer radiation technique called LATTICE radiotherapy compared to standard radiation for treating cancer tumors that have spread to other parts of the body. The goal is to see if the new approach works better and causes fewer side effects.
Palo Alto, CaliforniaAges 12 years+ - NCT07594691Recruiting
Breath-Hold Techniques to Improve Radiation Therapy Accuracy
This trial tests whether holding your breath during imaging scans can help doctors aim radiation therapy more precisely at upper abdominal cancers while protecting nearby healthy organs. The goal is to reduce side effects by improving treatment accuracy.
Toronto, OntarioAges 18 years+ - NCT06720532Recruiting
Kidney function in men with prostate cancer getting a new targeted radiation therapy
This study looks at how a targeted radiation therapy called 177Lu-PSMA affects kidney function in men with a type of advanced prostate cancer. It aims to understand risk factors to help guide safe treatment.
MunichAges 18 years+ - NCT02185443RecruitingPhase 2
SBRT radiation for liver metastases that can’t be surgically removed
This trial studies stereotactic body radiation therapy (high-precision radiation given in a few sessions) for liver metastases when surgery isn’t possible. It may help shrink or control tumors in the liver and delay progression in people whose cancer has not spread outside the liver (or only to areas treated with a curative plan).
São Paulo, São PauloAges 18 years+ - NCT07580703RecruitingPhase 1
Brain Imaging Study for Memory and Thinking Changes
This study tests a new type of brain scan (called [18F]Flortaucipir PET) that may help detect early signs of Alzheimer's disease. Researchers want to make sure the scan is safe and works well in Chinese patients aged 50–85 with normal thinking, mild memory problems, or Alzheimer's disease.
Beijing, Beijing MunicipalityAges 50–85 - NCT07578519RecruitingPhase 2
Personalized Radiation Therapy for Intermediate to High-Risk Prostate Cancer
This trial tests a new type of radiation therapy that is customized for each patient's prostate cancer. The radiation targets the tumor more precisely, which may help reduce side effects while treating the cancer effectively.
Lethbridge, AlbertaAges 18 years+ - NCT07586046RecruitingPhase 2
Radiation treatment for liver tumors
This study tests a higher dose of radiation delivered directly to liver tumors through small beads. It aims to improve tumor control while keeping side effects manageable for people whose liver cancer is not removable by surgery.
Chicago, IllinoisAges 18 years+ - NCT03394417Recruiting
StrataXRT skin gel to prevent rash during head and neck radiation
This trial tests whether a medicated skin gel (StrataXRT) can better prevent painful skin rash (“acute dermatitis”) in people with head and neck cancer who receive chemotherapy and radiation at the same time. If you’re eligible, you may get the study skin product and help doctors find a safer, more comfortable way to protect the skin during treatment.
SingaporeAges 21–80 - NCT07559877RecruitingPhase 3
Chlorhexidine spray to prevent radiation skin damage in throat cancer
This study tests whether a chlorhexidine spray (an antiseptic liquid) can prevent or reduce skin damage caused by radiation therapy in people being treated for nasopharyngeal cancer (cancer in the back of the nose/throat). Radiation dermatitis—painful redness and irritation of the skin—is a common side effect, and this spray may help protect your skin during treatment.
Nanchang, JiangxiAges 18–75
Hear when a new Radiation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for radiation?
- Yes. Clin2 currently lists 1,030 recruiting radiation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a radiation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a radiation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.